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In this volume, two important chapters focus on the area of
Immunoglobulins and B Cell Receptors. Serum antibody composition
is the result of tightly regulated differentiation of B lymphocytes into
antibody secreting cells (ASCs), plasma blasts, and plasma cells. To
maintain humoral memory, ASCs can be recruited to a pool of long-
lived plasma cells. Survival of the plasma cells is dependent of defined
signals provided in a limited number of survival niches in the body,
most prominently in the bone marrow. Thus, competition between newly
generated plasma blasts and old plasma cells for occupancy of survival
niches allows the immune system to maintain a stable humoral
immunological memory over long periods, to react to new pathogenic
challenges, and to adapt to humoral memory in response to these
antigens. R.A. MANZ et al. review current concepts on the biology of
ASCs with respect to their contribution to the maintenance of serum
antibody levels, humoral immunity, and humoral memory. H. JUMAA
et al. discuss recent progress in unravelling the molecular mechanisms
of signalling pathways that control simultaneously proliferation and
differentiation of early B cells.
Three chapters are dedicated to T Lymphocyte and NK Receptors.
The T cell antigen receptor (TCR) delivers signals that are crucial at
distinct stages of T cell development in the thymus, as well as for the
activation and differentiation of mature T cells into effector and memory
cells in the periphery. Recent studies discussed by M.E. CALL &
K.W. WUCHERPFENNIG established the great importance of the
cell membrane environment for protein-protein and protein-lipid
interactions that are critical for the assembly and function of the TCR-
CD3 complex. Natural killer (NK) cells discriminate between normal
cells and abnormal cells by using a repertoire of cell surface receptors
that control their activation, proliferation, and effector functions. NK
recognition includes the initial binding to potential target cells,
interactions between activating and inhibitory receptors with ligands
available on the target, and the interaction of signals transmitted by
these receptors, which determines whether the NK cell detaches and
moves on or stays and respond. In an excellent chapter, L.L. LANIER
focuses on the structure, signal transduction, and biological function
of the activating and inhibitory NK receptors, with particular emphasis
on those receptors with defined physiological ligands. Different classes
of NK receptors defined by their ligand specificity, e.g. receptors for
MHC class I, receptors for MHC class I-related ligands, and receptors
for host-encoded non-MHC ligands are discussed in this exciting review.
The Tec family nonreceptor tyrosine kinases have recently been
recognized as key mediators of antigen receptor signalling in
lymphocytes. This family consists of five family members, which are
expressed primarily in hematopoietic cells. In T cells, three major Tec
kinases are expressed, all of which are tyrosine phosphorylated upon
TCR stimulation. In a very interesting issue, L.J. BERG et al. cover
Tec family kinases as important regulators of TCR signalling that
contribute to activation of phospholipase C-γ. Recent studies suggesting
that Tec family kinases also regulate actin cytoskeletal reorganization
and cellular adhesion following TCR stimulation are also discussed.
The field of MHC and Antigen Processing and Presentation is
covered in two chapters. Plasmocitoid dendritic cell precursors (pDCs),
also known as type I interferon-producing cells (IPCs) display plasma
cell morphology, and selectively express Toll-like receptor (TLR)-7
and TLR-9. Upon viral infections, pDCs/IPCs rapidly produce large
amounts of type 1 interferon, which not only have direct inhibitory
effects on viral replication but also contribute to the activation of NK
cells, B cells, T cells, and mature DCs, leading to the induction and
expansion of an antiviral immune response. After producing large
amounts of type 1 IFN, pDC/IPCs rapidly differentiate into mature
DCs and may contribute to T cell regulation. Isolation and
characterization of human pDC/IPCs and regulation of T cell-mediated
immune responses by pDC/IPCs are discussed by Y-J LIU in a very
interesting review. The past several years have yielded great advances
in our understanding of the cells biology and biochemistry of antigen
processing and presentation. E.S. TROMBETTA & I. MELLMAN
summarize what we have learned about the functional attributes of
antigen-presenting cells (APCs), with special emphasis on dendritic
cells. Their overall organization, regulation, and intracellular transport
that both facilitate and modulate the processing of protein antigens are
discussed in a very didactic manner.
Two chapters in this volume deal with Lymphocyte Surface
Antigens. JP-Y TING et al. review the Cartepiller (CLR) family of
proteins, a new discovered family that appears to have its evolutionary
roots in plants and is likely an ancient family of genes. CLR is important
in controlling inflammation and apoptosis and likely has wide impact
not only in the immune system and organs/tissues rich with
inflammatory cells, but also may serve functions in nonimmune cells.
Pathways in the B7:CD28 family have key roles in regulating T cell
activation and tolerance and are promising therapeutic targets. Five
new B7 family members (ICOS ligand, PD-L1, PD-L2, B7-H3 and
B7-H4), that are expressed on professional antigen-presenting cells as
well as on cells within nonlymphoid organs, were recently identified.
R.J.GREENWALD et al. focus on recent advances in our
understanding of the functions of pathways in the B7:CD28 family.
First, they discuss recently identified immune and nonimmune function
of B7-1 and B7-2. Next, the authors summarize our current
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understanding of the new B7 family members in regulating T cell
activation and tolerance in peripheral tissue. Finally, their therapeutic
potential in autoimmunity, asthma and allergy, infectious diseases, and
transplantation is discussed.
In 2005, the important area of Cytokines is covered in five chapters.
TNF and its receptors have a diverse and complex set of interaction
with the immune system. They can influence inflammation and innate
immunity, lymphoid organization, or activation of antigen-presenting
cells (APCs), or they can provide direct signals to T cells. T.H. WATTS
focuses on several members of the TNFR/TNF ligand superfamily that
play a direct role in T cell responses subsequent to initial T cell
activation. Their potential therapeutic applications, including cancer,
infectious disease, transplantation, and autoimmunity are also
discussed. That secondary lymphoid organs are sites for immune
response initiation has long been known. Naïve B and T cells continually
enter secondary lymphoid organs from the blood and migrate within
minutes to the juxtaposed B cell follicles and T cell zones, respectively.
In a very interesting chapter, J.G. CYSTER first reviews the roles of
chemokines in cell homing to lymphoid follicles and T cell zones, and
in facilitating interactions between cells during the initiation of adaptive
immunity. Next, the author focuses on another type of soluble mediator,
a lysophospholipid (sphingosine-1-phosphate, (S1P), in lymphoid
trafficking. Finally, the author reviews information emerging on the
requirements from cell egress from secondary lymphoid organs and
thymus. The multiple subtypes of α-interferons and single β-interferon
belong to the type I family of interferons (IFNs) and are central to a
vast array of immunological functions. The broad effects of IFN-α/β
include innate immunity, and almost every aspect of cellular and
humoral adaptive immune responses. In the last years, a clear picture
of several aspects of their biology has emerged, including signalling
processes, priming capacity, cross-talk among themselves and other
cytokines, receptors and ligands involved in their production, and their
major cellular producers. In an excellent chapter, A.N.
THEOFILOPOULOS et al. review select aspects of the biology of
IFN-α/β related to these recent advances, with focus on their role in
systemic and organ-specific autoimmune diseases like systemic lupus
erythematosus and insulin-dependent diabetes mellitus, respectively.
Lymphotoxins (LTα and LTβ) together with the two related cytokines,
tumor necrosis factor (TNF) and LIGHT (LT-related inducible ligand
that competes for glycoprotein D binding to herpesvirus entry mediator
on T cells), form an integrated signalling network necessary for efficient
innate and adaptive immune responses (TL/TNF/LIGHT network). In
the clinic, TNF/LTα have proven to be important targets for suppressing
inflammation in certain autoimmune diseases, including rheumatoid
arthritis and inflammatory bowel syndrome, but not others, such as
multiple sclerosis. In an up-to-date issue, C.F. WARE first discusses
the structural and functional features of the LT/TNF/LIGHT signalling
systems. Next, the author reviews clinical results using LT/TNF/
inhibitors in various human autoimmune diseases. Finally, side effects
of TNF inhibitors which include increased susceptibility to certain
infectious diseases are discussed in a very didactic manner. Complement
system activation has recently been implicated in the pathogenesis of
many inflammatory and immunological diseases. The complement
activation exerts its harmful roles through the generation of complement
protein split products, especially C3a and C5a. Accumulating data
suggest that C5a is one of the most patent inflammatory peptides. R-F
GUO & P.A. WARD describe actions of C5a, focusing on its roles in
innate immunity and molecular and cellular events that lead to the
inflammatory sequelae. Human and animal experimental data
describing the cellular and molecular mechanisms of C5a in the
development of inflammatory disorders, sepsis, acute lung injury,
ischemic-reperfusion injury, and asthma are also discussed.
The area of Lymphocyte Development and Differentiation has
been the target for several publications in previous volumes of this
scientific series and much information has been obtained on this field.
The splenic marginal zone (MZ) is primarily made up of marginal
zone B cells (MZ B cells), specialized macrophages, and reticular
cells. In rodents, MZ B cells are now recognized as a distinct naïve B
lineage, separate from mature follicular (FO) B cells and B-1 cells.
In humans, most MZ B cells are thought to represent a memory
population. In a didactic and informative review, S. PILLAI et al.
review the mechanisms involved in the entry of B lymphocytes into
the MZ and their subsequent retention in this area. Next, the authors
focus on the functions of these cells in both innate and adaptive
immunity. Finally, the biology of human MZ B cells and their
relevance to disease are considered. Helper T cell-regulated B cell
immunity progresses in an ordered cascade of cellular development
that culminates in the production of antigen-specific memory B cells.
In a very interesting chapter, L.J. McHEYSER–WILLIAMS & M.G.
McHEYSER–WILLIAMS provide an overview of the cellular and
molecular regulators of this dynamic process with emphasis on the
multiple memory B cell fates that develop in vivo. T cell development,
as a process, incorporate multiple stages at which different choices
are available to the cells, extending over many cell cycles and a long
period of time. Moreover, T cell development is guided by a complex
set of key regulators throughout the process, in different combinations.
E.V. ROTHENBERG & T. TAGHON describe the modes of action
of the major T-lineage-defining transcription factors and the signal
pathways that activate them during intrathymic differentiation from
pluripotent precursors. DNA is degraded during programmed cell
death (apoptosis) that accompanies mammalian development. By the
other hand, as pointed out by S. NAGATA, there are “living” or at
least “functional” cells that not carry DNA, like erythrocytes and
lens fiber cells in the eyes. In these cell populations, DNA is removed
or degraded at the final stage of their differentiation into mature cells
by recently identified specific DNases. Additionally, mice deficient
in the respective DNase develop anemia and cataract, indicating that
DNA degradation is an essential step for differentiation of erythroid
cells and lens fiber cells. In a very interesting chapter, the author
reviews how DNA is degraded during apoptosis, erythroid cell
differentiation, and lens cell differentiation. There are several features
of natural killer T (NKT) cells that have emerged from studies carried
out during the previous decade. Despite this progress, knowledge of
the natural antigens they recognize and their physiologic role remain
incomplete. M. KRONENBERG reviews the known properties of
mouse and human NKT cells and focuses on recent findings and on
important unresolved questions concerning the development,
specificity, and function of these unique T lymphocyte. The Notch
pathway is a key regulator of developmental choices, differentiation,
and function throughout the hematolymphoid system. The diverse
functions of Notch are mediated through a conserved signalling
pathway in which transmembrane receptors undergo regulated
proteolysis and nuclear translocation to activate transcription. The
state-of-the-art of regulation of development, differentiation, and
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functions of peripheral T and B cells by the Notch pathway is
presented by I. MAILLARD et al.
Three exciting chapters deal with Phagocytosis and Inflammation.
Neutrophils constitute the first line of defense of the innate immune
system by phagocytosing, killing, and digesting bacteria and fungi.
During the past few years, there were many evidences implicating a
major primary role for the granule proteins in the killing process, with
a less direct but still facilitating and activating role for the respiratory
burst through the NADPH oxidase. This raises the question of the
connection between these two processes. In a very up to-date chapter,
A.W. SEGAL reviews recent progress in our understanding of the
relationship between the oxidase and granule enzyme activation in the
killing process.  Innate defense mechanisms consist of a cellular and a
humoral arm. Like the cellular arm, the humoral arm is also diverse: it
includes collectins (mannose–binding lectin, surfactant protein A and
D, C1q), ficolins, and pentraxins. C reactive protein (CRP) and serum
amyloid P (SAP) component are classic short pentraxins produced in
the liver. Long pentraxins, including the prototype PTX3, are produced
by a variety of cells and tissues, most notably dendritic cells and
macrophages, in response to Toll-like receptor engagement and
inflammatory cytokines. Current research suggests that PTX3 acts as
a functional ancestor of antibodies, recognizing microbes, activating
complement, and facilitating pathogen recognition by phagocytes. In
a very interesting review, C. GARLAND et al. summarize current
understanding of the structure and function of pentraxins with focus
on the more recently discovered long pentraxin PTX3, and on the classic
short pentraxins CRP and SAP. Macrophages express a broad range of
plasma membrane receptors that mediate their interactions with natural
and altered-self components of the host as well as a range of
microorganisms. Their ability to recognize a wide range of ligands,
and to responde appropriately, is central to macrophage functions in
homeostasis as well as host defense in innate and acquired immunity,
autoimmunity, inflammation, and immunopathology. The role of classic
opsonins (antibody and complement) and of a range of microbial ligands
by Toll-like receptors and families of cytosolic proteins (e.g. NODs,
NALPs) has been well documented. P.R. TAYLOR et al. review less
well-known receptor families implicated in nonopsonic recognition,
mediating either cell adhesion or phagocytosis.
The important area of Autoimmunity is covered in two chapters.
The nonobese diabetic mouse (NOD) strain is an excellent model of
autoimmune type 1 diabetes (T1D), which shares many similarities to
type 1a diabetes in human subjects. M.S. ANDERSON & J.A.
BLUESTONE first summarize recent advances in our understanding
of disease development and progression in the NOD mice. Next, the
authors highlight how these findings will lead to potential therapies
for the treatment of autoimmune diabetes. Multiple sclerosis (MS) is
an inflammatory disease that affects the central nervous system (CNS).
It leads to substantial disability through deficits of sensation and of
motor, autonomic, and neurocognitive function. MS is still considered
a CD4+Th1-mediated autoimmune disease. Damage of the target tissue
(CNS) is, however, most likely mediated by other components of the
immune system, such as antibodies, complement, CD8+T cells, and
factors produced by innate immune cells. In a very exciting chapter,
M. SOSPEDRA & R. MARTIN, as pointed out by the authors
themselves, deviate from their review 12 years ago and consider the
role of the CNS in targeting the disease process, in interactions with
the immune system, and in the long-term course of MS.
The field of ALLERGY includes only one chapter by S.J. GALLI
et al. covering current progress in mast cells knowledge. First, the
authors summarize current understanding of the positive and negative
regulation of signaling in mast cells via the FcεRI, including recent
work indicating that the mast cell functional properties can be modified
by action of IgE in the absence of known antigen. Next, they advance
the hypothesis that mast cells also may contribute to the initiation and
regulation of acquired immune responses. Finally, the authors illustrate
how mast cell knockin mice have been used to identify and characterize
the potentially diverse contributions of mast cells to the induction,
expression, and regulation of IgE– associated and other acquired
immune responses.
Two chapters in this volume deal with Immunology of Infectious
Diseases and Vaccines. Malaria remains one of the world’s greatest
public health challengers and the immune response to the malaria
parasite is very complex. Although there is evidence from human and
animal model systems that cellular mediated immunity (CMI) can
control parasite load, the factors that regulate CMI are poorly
understood. M.F. GOOD et al. analyze the contribution of cellular
immune responses to both protection from malaria and pathogenesis.
CD8+T cells play a critical role in antiviral immunity by exerting direct
antiviral activity against infected cells. As pointed out by J.W.
YEWDELL & S.M. MANSOUR HAERYFAR in their chapter,
understanding of antiviral TCD8+ responses requires answering the
following questions: Which cells present antigen? Where and when
does this occur? In a very didactic manner, the authors focus on recent
progress obtained by in vivo studies in mice to understand the basis
for activation of naïve TCD8+ in virus infections.
Finally, in his prefatory chapter, Tadamitsu Kishimoto summarizes
his 40 years of research in immunology. He spent part of his professional
life studying one of the factors derived from culture supernatant of T
cells that induces proliferation and differentiation of B cells,
interleukin–6 (IL– 6). He “feels exceptionally fortunate that his life´s
work not only revealed the framework of cytokine signaling, but also
led to the development of a new therapy for chronic inflammatory
diseases”.
This volume 23 of the Annual Review of Immunology offers a
broad of recent information on selected topics in Basic Immunology,
and is mostly targeted to posgraduates and researchers in various fields
of Immunology.
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